Bioventus Inc.

8.15-0.2900-3.44%Vol 823.75K1Y Perf -53.24%
Jun 24th, 2022 16:00 DELAYED
BID8.03 ASK8.96
Open8.48 Previous Close8.44
Pre-Market- After-Market8.15
 - -  - -%
Target Price
20.67 
Analyst Rating
Strong Buy 1.00
Potential %
153.62 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
     39.19
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★     45.38
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
6.65 
Earnings Rating
Market Cap500.08M 
Earnings Date
9th Aug 2022
Alpha-0.01 Standard Deviation0.14
Beta1.47 

Today's Price Range

8.108.65

52W Range

7.3119.94

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-10.73%
1 Month
-6.43%
3 Months
-37.45%
6 Months
-41.70%
1 Year
-53.24%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
BVS8.15-0.2900-3.44
AAPL141.663.39002.45
GOOG2 370.76117.07005.19
MSFT267.708.84003.41
XOM86.901.69001.98
WFC40.762.86007.55
JNJ182.292.63001.46
FB196.640.99000.51
GE67.083.01004.70
JPM117.323.40002.98
Financial StrengthValueIndustryS&P 500US Markets
0.90
1.40
0.44
0.82
-14.90
Leverage Ratio 3.10
ProfitabilityValueIndustryS&P 500US Markets
68.40
-7.30
1.40
-1.30
-6.38
RevenueValueIndustryS&P 500US Markets
466.41M
7.60
18.03
16.67
Earnings HistoryEstimateReportedSurprise %
Q01 20220.010.04300.00
Q04 20210.200.2630.00
Q03 20210.130.2592.31
Q02 20210.100.1660.00
Q01 20210.04-0.02-150.00
Q04 2020-2.32-
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date9th Aug 2022
Estimated EPS Next Report0.16
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume823.75K
Shares Outstanding61.36K
Shares Float38.76M
Trades Count5.37K
Dollar Volume6.81M
Avg. Volume244.69K
Avg. Weekly Volume247.12K
Avg. Monthly Volume225.71K
Avg. Quarterly Volume261.23K

Bioventus Inc. (NASDAQ: BVS) stock closed at 8.15 per share at the end of the most recent trading day (a -3.44% change compared to the prior day closing price) with a volume of 823.75K shares and market capitalization of 500.08M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 680 people. Bioventus Inc. CEO is Kenneth M. Reali.

The one-year performance of Bioventus Inc. stock is -53.24%, while year-to-date (YTD) performance is -43.75%. BVS stock has a five-year performance of %. Its 52-week range is between 7.31 and 19.9409, which gives BVS stock a 52-week price range ratio of 6.65%

Bioventus Inc. currently has a PE ratio of 58.80, a price-to-book (PB) ratio of 1.25, a price-to-sale (PS) ratio of 1.20, a price to cashflow ratio of 28.00, a PEG ratio of 2.32, a ROA of -1.83%, a ROC of -2.94% and a ROE of -5.69%. The company’s profit margin is -6.38%, its EBITDA margin is 1.40%, and its revenue ttm is $466.41 Million , which makes it $7.60 revenue per share.

Of the last four earnings reports from Bioventus Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.16 for the next earnings report. Bioventus Inc.’s next earnings report date is 09th Aug 2022.

The consensus rating of Wall Street analysts for Bioventus Inc. is Strong Buy (1), with a target price of $20.67, which is +153.62% compared to the current price. The earnings rating for Bioventus Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bioventus Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Bioventus Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.21, ATR14 : 0.54, CCI20 : -159.68, Chaikin Money Flow : 0.01, MACD : -0.36, Money Flow Index : 29.08, ROC : -15.46, RSI : 36.45, STOCH (14,3) : 2.79, STOCH RSI : 0.00, UO : 36.22, Williams %R : -97.21), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bioventus Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Bioventus Inc.

Bioventus Inc is a medical technology company. The Company is engaged in developing and commercializing orthobiologic products for the treatment of patients suffering from a broad array of musculoskeletal conditions.

CEO: Kenneth M. Reali

Telephone: +1 919 474-6700

Address: 4721 Emperor Boulevard, Durham 27703, NC, US

Number of employees: 680

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

54%46%

Bearish Bullish

56%44%

TipRanks News for BVS

Tue, 15 Mar 2022 12:45 GMT Bioventus (BVS) Receives a New Rating from Craig-Hallum

- TipRanks. All rights reserved.

News

Stocktwits